OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,595,056 | -31.2% | 1,781,865 | +13.0% | 0.00% | – |
| Q2 2023 | $8,133,259 | +3.4% | 1,576,213 | +5.6% | 0.00% | – |
| Q1 2023 | $7,867,894 | +0.9% | 1,492,959 | -46.2% | 0.00% | – |
| Q4 2022 | $7,796,806 | +34.3% | 2,774,664 | +98.3% | 0.00% | – |
| Q3 2022 | $5,807,000 | +2.3% | 1,399,346 | -0.9% | 0.00% | – |
| Q2 2022 | $5,676,000 | -32.7% | 1,411,827 | -17.2% | 0.00% | – |
| Q1 2022 | $8,439,000 | -30.0% | 1,704,934 | -1.5% | 0.00% | -100.0% |
| Q4 2021 | $12,061,000 | -27.9% | 1,730,356 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $16,731,000 | -32.1% | 1,673,050 | -3.8% | 0.00% | 0.0% |
| Q2 2021 | $24,652,000 | -1.0% | 1,738,472 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $24,904,000 | -17.3% | 1,517,617 | +4.3% | 0.00% | -50.0% |
| Q4 2020 | $30,118,000 | +244.3% | 1,454,954 | +26.6% | 0.00% | +100.0% |
| Q3 2020 | $8,747,000 | +15.9% | 1,149,467 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $7,547,000 | +86.8% | 905,982 | +11.0% | 0.00% | – |
| Q1 2020 | $4,040,000 | +44.8% | 816,201 | +15.5% | 0.00% | – |
| Q4 2019 | $2,791,000 | +36.4% | 706,567 | +5.0% | 0.00% | – |
| Q3 2019 | $2,046,000 | -19.9% | 672,896 | +15.9% | 0.00% | – |
| Q2 2019 | $2,555,000 | +23.4% | 580,731 | +11.4% | 0.00% | – |
| Q1 2019 | $2,070,000 | +7.3% | 521,326 | +7.6% | 0.00% | – |
| Q4 2018 | $1,929,000 | -40.8% | 484,677 | +2.4% | 0.00% | – |
| Q3 2018 | $3,256,000 | +11.4% | 473,294 | +9.3% | 0.00% | – |
| Q2 2018 | $2,924,000 | +19.9% | 432,980 | +15.8% | 0.00% | – |
| Q1 2018 | $2,439,000 | +55.8% | 373,923 | +6.2% | 0.00% | – |
| Q4 2017 | $1,565,000 | -28.1% | 352,141 | +0.1% | 0.00% | – |
| Q3 2017 | $2,176,000 | -36.9% | 351,880 | -5.4% | 0.00% | – |
| Q2 2017 | $3,450,000 | +12.2% | 371,923 | +12.3% | 0.00% | – |
| Q1 2017 | $3,076,000 | +53.8% | 331,141 | +38.6% | 0.00% | – |
| Q4 2016 | $2,000,000 | +48.1% | 238,921 | +21.8% | 0.00% | – |
| Q3 2016 | $1,350,000 | +33.1% | 196,160 | -4.5% | 0.00% | – |
| Q2 2016 | $1,014,000 | -49.0% | 205,309 | -0.1% | 0.00% | – |
| Q1 2016 | $1,989,000 | +17.4% | 205,586 | +13.8% | 0.00% | – |
| Q4 2015 | $1,694,000 | -31.8% | 180,647 | +2.1% | 0.00% | – |
| Q3 2015 | $2,485,000 | -5.4% | 176,949 | +41.7% | 0.00% | – |
| Q2 2015 | $2,626,000 | -10.8% | 124,900 | +78.1% | 0.00% | – |
| Q1 2015 | $2,943,000 | +165.6% | 70,129 | +48.9% | 0.00% | – |
| Q4 2014 | $1,108,000 | +85.9% | 47,100 | +18.0% | 0.00% | – |
| Q3 2014 | $596,000 | – | 39,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |